NZ215910A - Cyclopentyl ethers and pharmaceutical compositions - Google Patents

Cyclopentyl ethers and pharmaceutical compositions

Info

Publication number
NZ215910A
NZ215910A NZ215910A NZ21591086A NZ215910A NZ 215910 A NZ215910 A NZ 215910A NZ 215910 A NZ215910 A NZ 215910A NZ 21591086 A NZ21591086 A NZ 21591086A NZ 215910 A NZ215910 A NZ 215910A
Authority
NZ
New Zealand
Prior art keywords
pharmaceutical compositions
cyclopentyl ethers
cyclopentyl
ethers
pharmaceutical
Prior art date
Application number
NZ215910A
Other languages
English (en)
Inventor
E W Collington
H Finch
D B Judd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NZ215910A publication Critical patent/NZ215910A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ215910A 1985-04-23 1986-04-22 Cyclopentyl ethers and pharmaceutical compositions NZ215910A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858510277A GB8510277D0 (en) 1985-04-23 1985-04-23 Carbocyclic compounds

Publications (1)

Publication Number Publication Date
NZ215910A true NZ215910A (en) 1989-08-29

Family

ID=10578043

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ215910A NZ215910A (en) 1985-04-23 1986-04-22 Cyclopentyl ethers and pharmaceutical compositions

Country Status (29)

Country Link
JP (1) JPS61249951A (sv)
KR (1) KR860008132A (sv)
CN (1) CN1011783B (sv)
AT (1) AT395421B (sv)
AU (1) AU593797B2 (sv)
BE (1) BE904656A (sv)
CA (1) CA1275094A (sv)
CH (1) CH667265A5 (sv)
DE (1) DE3613573A1 (sv)
DK (1) DK183986A (sv)
ES (3) ES8802137A1 (sv)
FI (1) FI85368C (sv)
FR (1) FR2580632B1 (sv)
GB (2) GB8510277D0 (sv)
GR (1) GR861060B (sv)
HK (1) HK51691A (sv)
HU (1) HU199411B (sv)
IL (1) IL78552A (sv)
IT (1) IT1190277B (sv)
LU (1) LU86404A1 (sv)
MY (1) MY100829A (sv)
NL (1) NL8601025A (sv)
NO (1) NO165069C (sv)
NZ (1) NZ215910A (sv)
PH (1) PH23597A (sv)
PT (1) PT82440B (sv)
SE (1) SE460193B (sv)
SG (1) SG92990G (sv)
ZA (1) ZA863006B (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8625326D0 (en) * 1986-10-22 1986-11-26 Glaxo Group Ltd Medicaments
GB8625321D0 (en) * 1986-10-22 1986-11-26 Glaxo Group Ltd Chemical compounds
DE3764233D1 (de) * 1986-10-22 1990-09-13 Glaxo Group Ltd Cyclopentylaether, deren herstellung und pharmazeutische formulierung.
GB8625322D0 (en) * 1986-10-22 1986-11-26 Glaxo Group Ltd Chemical compounds
GB8625325D0 (en) * 1986-10-22 1986-11-26 Glaxo Group Ltd Chemical compounds
US5227505A (en) * 1987-06-16 1993-07-13 Nissan Chemical Industries, Ltd. Substituted cyclic ketones, substituted cyclic enones, and process for producing the same
JP2696933B2 (ja) * 1987-06-16 1998-01-14 日産化学工業株式会社 置換環状ケトン及び置換環状エノン並びにそれらの製造法
US5254708A (en) * 1987-06-16 1993-10-19 Nissan Chemical Industries, Ltd. Substituted cyclic ketones, substituted cyclic enones, and process for producing the same
US5231208A (en) * 1987-06-16 1993-07-27 Nissan Chemical Industries, Ltd. Substituted cyclic ketones, substituted cyclic enones, and process for producing the same
GB8822141D0 (en) * 1988-09-21 1988-10-26 Glaxo Group Ltd Chemical compounds
WO1999032441A1 (en) * 1997-12-22 1999-07-01 Alcon Laboratories, Inc. 13-oxa prostaglandins for the treatment of glaucoma and ocular hypertension
WO2005009468A1 (ja) 2003-07-25 2005-02-03 Ono Pharmaceutical Co., Ltd. 軟骨関連疾患治療剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2082176B (en) * 1980-08-12 1984-07-11 Sanofi Sa Heteroprostaglandin derivatives and processes for preparing them
NZ197729A (en) * 1980-08-12 1985-03-20 Sanofi Sa 13-oxaprostanoic acid derivatives and pharmaceutical compositions
GB8410396D0 (en) * 1984-04-24 1984-05-31 Glaxo Group Ltd Carbocyclic compounds

Also Published As

Publication number Publication date
AU5646186A (en) 1986-10-30
CN86102778A (zh) 1986-10-22
BE904656A (fr) 1986-10-22
LU86404A1 (fr) 1986-11-05
AT395421B (de) 1992-12-28
ES554238A0 (es) 1988-04-01
FR2580632B1 (fr) 1989-09-15
IL78552A (en) 1989-12-15
FI861687A (fi) 1986-10-24
ATA106986A (de) 1992-05-15
FI85368B (fi) 1991-12-31
GR861060B (en) 1986-08-25
IT1190277B (it) 1988-02-16
NO861584L (no) 1986-10-24
GB8510277D0 (en) 1985-05-30
MY100829A (en) 1991-03-15
GB2174702B (en) 1988-06-15
NO165069C (no) 1990-12-19
ES8900044A1 (es) 1988-11-16
PT82440B (pt) 1988-03-03
ES557828A0 (es) 1990-02-16
HU199411B (en) 1990-02-28
SE8601852D0 (sv) 1986-04-22
DK183986D0 (da) 1986-04-22
NO165069B (no) 1990-09-10
DK183986A (da) 1986-10-24
ES557659A0 (es) 1988-11-16
KR860008132A (ko) 1986-11-12
IT8647919A0 (it) 1986-04-22
JPS61249951A (ja) 1986-11-07
ES8802137A1 (es) 1988-04-01
CH667265A5 (de) 1988-09-30
HUT45010A (en) 1988-05-30
PT82440A (en) 1986-05-01
HK51691A (en) 1991-07-12
SE8601852L (sv) 1986-10-24
CN1011783B (zh) 1991-02-27
GB2174702A (en) 1986-11-12
ZA863006B (en) 1986-12-30
GB8609821D0 (en) 1986-05-29
PH23597A (en) 1989-09-11
IL78552A0 (en) 1986-08-31
ES9000022A1 (es) 1990-02-16
SG92990G (en) 1991-01-18
FI85368C (sv) 1992-04-10
FI861687A0 (fi) 1986-04-22
SE460193B (sv) 1989-09-18
AU593797B2 (en) 1990-02-22
CA1275094A (en) 1990-10-09
DE3613573A1 (de) 1986-10-30
FR2580632A1 (fr) 1986-10-24
NL8601025A (nl) 1986-11-17

Similar Documents

Publication Publication Date Title
NZ211145A (en) 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions
NZ212005A (en) Pyrrolobenzimidazoles and pharmaceutical compositions
NZ222980A (en) 3-aryloxy-3-substituted propanamines and pharmaceutical compositions
NZ223096A (en) Peptidylaminodiols and pharmaceutical compositions
IL74758A0 (en) Acyltripeptides and pharmaceutical compositions containing them
NZ216793A (en) Phenethanolaminotetraline derivatives and pharmaceutical compositions
NZ212099A (en) Substituted arylhydroxamates and pharmaceutical compositions
NZ211822A (en) Phenethanolamine derivatives and pharmaceutical compositions
NZ211031A (en) 6-substituted-4-dialkylaminotetrahindole derivatives and pharmaceutical compositions
NZ220020A (en) 1-hydroxy-2-pyridones and pharmaceutical composition
NZ212108A (en) Aminocyclopentyl ethers and pharmaceutical compositions
NZ214821A (en) Spiro-dioxolanes, -dithiolanes and -oxothiolanes and pharmaceutical compositions
NZ215910A (en) Cyclopentyl ethers and pharmaceutical compositions
NZ210818A (en) 8-alpha-acylaminoergoline derivatives and pharmaceutical compositions
NZ217078A (en) N-piperidyl-benzamide derivatives and pharmaceutical compositions
NZ215753A (en) Phenethanolamine derivatives and pharmaceutical compositions
NZ212953A (en) 3-acyl-1-aminoalkyl-1h-indoles and pharmaceutical compositions thereof
NZ215070A (en) Imidazole-indoles and pharmaceutical compositions
NZ216720A (en) Diazinylpiperidine derivatives and pharmaceutical compositions
IL79003A0 (en) Tetrahydroimidazoquinazolinones and pharmaceutical compositions containing them
NZ216438A (en) Steroid-pyrazoles and pharmaceutical compositions
NZ213581A (en) Carboxyalkyldipeptides and pharmaceutical compositions
NZ219748A (en) Indenopyrimidines and pharmaceutical compositions
IL74667A (en) Spiro-oxazolidones,-thiazolidones and-imidazolidones and pharmaceutical compositions containing them
NZ214815A (en) 12-aminopyridazinopyrroloisoquinoline derivatives and pharmaceutical compositions